Diabetes: Hydrogel system for GLP-1 agonists may reduce inje

Having daily or weekly injections of GLP-1 agonists such as Ozempic and Wegovy may become a thing of the past for people with diabetes with a new hydrogel drug delivery system.

Related Keywords

Matthew Webber , John Fredricks Nurphoto , Eric Appel , Sumera Ahmed , Jason Ng Of The University Pittsburgh , Touro University , University Of Notre Dame , Stanford University , Cell Reports , Medical News , Notre Dame ,